Vetr Urges Buy On Antares Post-Correction
October 17, 2017 at 07:47 AM EDT
The Vetr crowd on Monday upgraded its rating on Antares Pharma Inc (NASDAQ: ATRS) from 3 stars (Hold), issued four days ago, to 5 stars ...
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.